CBD and THC - Meet Your New Neighbors

 
CONTINUE READING
CBD and THC - Meet Your New Neighbors
CBD and THC – Meet Your
New Neighbors
Darrin Grondel
Vice President, Government Relations and
Traffic Safety – Responsibility.org /
National Alliance to Stop Impaired Driving

Amy Miles
Director of Forensic Toxicology, National
Resource Toxicologist – WI State Lab of
Hygiene, UW School of Medicine and
Public Health
                                             1
CBD and THC - Meet Your New Neighbors
Session Objectives

• Discuss the national perspective and rules around CBD, THC and
  isomers

• Outline the toxicology of CBD, THC and isomers and adulterants

• Explain Computerized Assessment and Referral System (CARS) to
  identify substance abuse and mental health issues

                                                                   2
CBD and THC - Meet Your New Neighbors
Darrin – national
perspective

                    3
CBD and THC - Meet Your New Neighbors
What do we know about Cannabis?

   480 Chemical Compounds                                      Cannabigerol CBG
   66 – 113 cannabinoid compounds                              Cannabichromenes-CBC
   Delta 9 – THC (1964)                                        Cannabinodial CBDL
   now Delta 8, 9, 10, 11,?                                    Cannabicyclol CBL
   Cannabinol CBN (1899)                                       Cannabielsoin CBE
   Cannabidiol CBD (1963)                                      Cannabitriol CBT
                                                               Cannabidivarin CBDV

http://learnaboutmarijuanawa.org/factsheets/cannabinoids.htm
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/

                                                                                      4
CBD and THC - Meet Your New Neighbors
SIGNS AND SYMPTOMS of MJ
IMPAIRMENT
THC/CBD and similar
compounds bind with
receptors (CB1 and CB2)
in the brain and other
parts of the body
affecting the function of
the hippocampus (short-
term memory),
cerebellum
(coordination) and basal
ganglia (unconscious
muscle movements).
                            • Marijuana is a lipid (fat) soluble and tends to stay in the brain

                            • Alcohol is water soluble - blood                              Reference - http://www.brainwaves.com/

                                                                                                                                     5
CBD and THC - Meet Your New Neighbors
https://cbd.market/cbdblog/cbd-oil-legality-in-usa

                                                     6
CBD and THC - Meet Your New Neighbors
Hemp vs. Marijuana?
                            • Morphological characteristics of the plant (macroscopic,
                              microscopic, smell, etc.) are exactly the same.

                            • A person cannot tell the difference by looking at or smelling
                              the plant.

                            • The only way to differentiate is through laboratory testing to
                              determine THC concentration.

                            • How does the user know what they are consuming – the
                              packaging!

  https://www.endoca.com/

                                                                                               7
CBD and THC - Meet Your New Neighbors
Regulation of CBD
•   Is CBD legal in the U.S? Agricultural Improvement Act – the 2018 Farm Bill allows for CBD from Hemp – Sativa Plant

•   Federal - Food and Drug Administration has not approved CBD for any disease or condition
     •   Exception - Epidiolex – Purified form of CBD – Seizures - Lennox-Gastaut syndrome or Dravet syndrome, and tuberous
        sclerosis complex.
     • Prescribed by a medical provider and medication guide due the impacts

•   The Federal Food, Drug and Cosmetic Act (FD&C) addresses unapproved products with product claims it treats, diagnosis,
    mitigates, treats or cures various diseases.

•   Is it legal in your State? Check your state laws as they differ (https://www.ncsl.org/research/health/state-medical-marijuana-
    laws.aspx)
      • Some states legalized for CBD products that are approved by the Food and Drug Administration (FDA), so is this a
           safeguard for the state?
            • Some include both FDA approval and
CBD and THC - Meet Your New Neighbors
Regulation

•   Manufacturing process of CBD products has not been assessed by the FDA

•   “A regulatory standard for labeling accuracy of CBD does not exist” (Geoffrey et al, 2021)

•   No third-party regulatory process nationally or at state level to verify product ingredients, contaminants, or quality.

•   FDA sent out five warning letters in December of 2020 to companies who are illegally selling unapproved CBD
     products in violation of the FD&C.

• Impaired Driving – the FDA found that CBD can cause sleepiness, sedation, and lethargy, based on their research
with Epidiolex. Remember, if stopped and taking CBD products with THC concentrations, the THC could be
detected.

                                                                                                                              9
CBD and THC - Meet Your New Neighbors
Regulation – Labeling – Adulteration
• Horth, R. Z. et al, Acute poisonings from a Synthetic Cannabinoid - Utah 2017- 2018

• Clear case of why we need regulation, accuracy in labeling and concerns of adulteration

• 52 people identified

• Branded as “YOLO CBD Oil”

• “Nine product samples (including one unopened product purchased by investigators from a store and brand
  reported by a patient) were found to contain a synthetic cannabinoid, 4-cyano CUMYL-BUTINACA (4-CCB), but
  no CBD.”

• Symptoms – altered mental state, nausea or vomiting, and seizures or shaking, anxiety, unconsciousness.

• 73% vaped, 17% sublingual

• 67% Recreational, 28.8% Medical,

                                                                                                            10
Adulterations
       CBD products are not regulated and is subject to concerns about product labeling, contaminants, or
                                               adulterations…

 (Gurley et al., 2020) research on labeling consistency for cannabidiol (CBD) products examined
 25 different commercial samples obtained in the state of Mississippi.
 •Only three were within 20% of claimed labeling
 •15 were well below stated claims
 •Two exceeded claims by more than 50%
 •Three exceeded the legal limit of 0.3% THC content
 •Four products marketed for vaping were contaminated with synthetic cannabinoids (potential
 for acute and chronic health effects)

Gurley, B. J., Murphy, T. P., Gul, W., Walker, L. A., & ElSohly, M. (2020). Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi. Journal of
Dietary Supplements, 17(5), 599–607. https://doi.org/10.1080/19390211.2020.1766634

                                                                                                                                                                                                                            11
THC Concentrations over the Years

         1973                  3%

                2008                            10%

                               2019                       20%
                                                           -
                   Cannabis flower being sold in stores
                                                          30%

                                                                12
THC Potency Used In
Most Government Studies addressing crash risk

                                                13
Toxicology of THC,
THC isomers and
CBD

                     14
CANNABINOIDS

• D9 most readily
  studied of all isomers
• D8, D10 quickly
  becoming prolific as
  alternative to D9 with
  limited scientific data
• CBD still available,
  reports of users
  turning to isomers
• Active metabolite of
  D9 = 11-hydroxy-THC
• Route of
  administration effects
  metabolite ration
  profile
Route of Administration
• Oral
   • Edibles
• Smoking
   • Vaping
   • Typical smoking
• Concentrates
   • Oils
   • Waxes

                          16
Delta-9-THC (parent)
  Psychoactive component in THC
  Very short half life
11-Hydroxy-THC (metabolite)
  Equipotent to delta-9-THC at certain
  concentrations
  Very short half life
Carboxy-THC (metabolite) *Only
reported analyte for urine*
  No psychoactive impairment
  Longer half life

                                         17
The Feel Good Factory

                        18
Contains 20% CBD   Contains 10% CBD

                                      19
Delta - 7    Delta - 8

THC Isomers

              Delta - 10       ?

                                       20
Shutterstock

               21
Consumer Products

                    22
Regulations?

• No FDA oversight

• “Tested” products are
  misleading

• Common adulterants
  include synthetic
  cannabinoids

                          23
24
• Products contained an excess of 0.3% THC

• Synthetic cannabinoids detected in products marketed for vaping

• “From this small, but diverse, samples of hemp-derived merchandise,
  it appears that most product label claims do not accurately reflect
  actual CBD content and are fraudulent in that regard.”

                                                                        25
Case Histories

                 26
Cannabis Impairment
Detection Workshops

                      27
Cannabis Impairment Detection
           Workshop Handbook:
    o New publication from the National District Attorneys
      Association’s National Traffic Law Center and
      Responsibility.org
    o Provides answers on how to host and conduct Green
      Labs
    o Potential issues highlighted with solutions
    o Addresses LE hosted workshops and those conducted
      by contractors

o Recently utilized by Maryland State Police for their police
  agency-hosted workshop
https://www.responsibility.org/wp-content/uploads/2020/11/FAAR_4090-Cannabis-Impairment-Detection-Workshop-Handbook_V-3-002.pdf

                                                                                                                                  28
HOW:
Classroom curriculum:
Potential topics-
 • Current products available
 • Ingestion methods and
   consideration of duration of effects
 • THC v. CBD
 • Different types of high
   (Indica/Sativa strains)
 • Polydrug use (cannabis and alcohol)
 • How cannabis impairs a driver
 • General indicators of impairment
 • SFSTs/ARIDE roadside tests and how
   they specifically point to cannabis
   impairment
 • Wrap up / critique
HOW:
 Lab/workshop curriculum
  Potential Topics-
   ❖General indicators of cannabis impairment
   ❖SFSTs/ARIDE roadside tests and how they
     specifically point to cannabis impairment
   o HGN expectations
   o Importance of ARIDE tests
   o Frequent users versus occasional users
   o Oral fluid as a screening device roadside
     tool
   o Q & A with consumers
• Direct interaction with users in a
  controlled environment at optimal
  impairment time
• Medic present
Enforcement (optional)
      o To be conducted directly following training (classroom &
        lab)
      o Saturation patrol and/or checkpoints
          o Events in the area (concerts, festivals)
          o Important dates (April 20th, July 10th)

             Montgomery County stats after first lab:
•   Total traffic stops:47 stops
•   Total traffic citations: 40 citations
•   Total traffic warnings: 47 warnings
•   Additional:
•   1 DUID (DRE performed-determined to be under the
    influence of cannabis)
•   1 DUI alcohol
•   2 Civil citations for possession of marijuana under 10
    grams
•   1 PWID marijuana arrest ($1760.00 seized along with
    marijuana)
Computerized
Assessment and
Referral System
(CARS)

                  32
High Risk Impaired Drivers
                   Conviction Focused Approach                             Individualized Justice Approach
      Law enforcement trained only on alcohol                  Expanded DUID training (ARIDE, DRE, oral fluid)
      Test only for alcohol if per set limit reached           Test for alcohol and drugs
      Multiple prosecutors handle a single DUI case            Vertical prosecution
      Cases heard in criminal/civil courts                     DUI and treatment courts
      Inconsistent screening & assessment using generic tools Screening & assessment at multiple phases using tools
                                                              validated specifically among the DUI population

      Emphasis on punishment (fines & jail) as prescribed in   Investment in treatment and supervision determined by
      statute                                                  multidisciplinary team and informed by assessment

      Probation generalists                                    Mental Health/SUD probation specialists
      Siloed data systems                                      Linked impaired driving data system

                                     Leverage your State DUI Task Force or
                                        Impaired Driving Work Groups
High Risk and Repeat Offenders

34
Criminogenic Risk Factors

           History of                   Family/
                         Anti-social                Leisure/
           anti-social                  marital
                         cognitions                recreation
            behavior                    discord

          Anti-social
                         Anti-social   Substance    School/
          personality
                         associates      abuse       work
           pattern

35
Mental Health?

       While not a criminogenic need, it is imperative that mental health issues be
       identified and treated to adequately address other risk factors.

36
Development of CARS
 •   CARS was developed by a team of researchers from Cambridge Health Alliance, a teaching affiliate of
     Harvard Medical School.
      – Initial grant funding was provided by NIAAA; Responsibility.org continues to fund CARS research and
        implementation.

 •   The goal was to create an assessment tool specifically for a DUI offender population that fills the mental
     health void that exists with traditional instruments.

37
38
What is CARS?
                                Diagnostic
                                  report
                                generator

                                Mental
                    Case                         Brief
                 management     health       intervention
                              assessment

                                Referral
                                database

39
What is CARS?
 •   Diagnostic report generator that gives providers and clients:
      – Immediate diagnostic information for up to 20 DSM-V Axis I disorders (onset, recency, persistence).
      – Geographically and individually targeted referrals to                treatment services based on the
        outcomes of the assessment.

                        Substance
                       dependence
                                                        Intervention
                      Mental health
                        issues

40
CARS comprehensive mental health screener domains
         Panic disorder               Social phobia               Eating disorders

                              Attention deficit/hyperactivity   Obsessive compulsive
     Intermittent explosive              disorder                     disorder
           disorder

          Depression               Generalized anxiety               Suicidality

     Mania/bipolar disorder   Post-traumatic stress disorder      Conduct disorder

      Oppositional defiant              Psychosis               Nicotine dependence
           disorder

      Alcohol use disorder          Drug use disorder            Gambling disorder

     Psychosocial stressors       DUI/criminal behavior

41
How does CARS work?

42
How does CARS work?
 •   Individual diagnostic reports have been programmed to provide
     information about the mental health disorders for which a person
     qualifies or is at risk, as well as a summary of bio-psycho-social risk
     factors.
 •   The CARS tool includes a section on DUI behavior.
      – The data obtained from the questions in this section is integrated
        with other risk factors to generate an overall DUI recidivism risk
        score.
      – A graphic is generated as part of the outcomes report that indicates
        where an individual is within a range of low to very high risk.

43
CARS Report

44
CARS Report

45
Bridging the gap…
     • Unlike traditional assessments,
       CARS has a built-in referral system.
     • CARS has been designed to include
       a list of individually-targeted
       referrals at the end of each report
       based on an individual’s issues and
       zip code.
     • Before CARS can be implemented,
       the referral list must be populated
       with treatment services that are
       available within that jurisdiction.

46
Benefit of CARS
 •   Provides immediate diagnostic information for up to 20 major psychiatric disorders.

 •   Provides geographically and individually targeted referrals to appropriate treatment services.

 •   Generates user-friendly reports at the click of a button.

 •   Informs supervision and treatment decisions.

 •   Runs on free open-source software.

 •   Can be used by non-clinicians.

 •   Applicable in a number of settings.

47
National Roll-Out
                     CARS was launched for
                     general use in June 2017.
                     Available to any court,
                     probation department, or
                     program free of cost.
                     Online web portal for
                     downloads and training:
                     www.carstrainingcenter.org
48
Contact Information

                         Darrin T. Grondel
     Vice President – Government Relations and Traffic Safety
                Darrin.Grondel@Responsibility.org
                          571-309-7615

                          Amy Miles
                Director of Forensic Toxicology
             Wisconsin State Laboratory of Hygiene
            UW School of Medicine and Public Health
                    Direct: 608-224-6247
                   amy.miles@slh.wisc.edu
         /GoFAAR     @goFAAR      @go_FAAR      /faar       /GoFAAR
49
You can also read